 | • レポートコード：GIR201109991 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、チロシンキナーゼ阻害剤の世界市場を調査対象にし、チロシンキナーゼ阻害剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（BCR-ABLチロシンキナーゼ阻害剤、上皮増殖因子受容体（EGFR）チロシンキナーゼ阻害剤、血管内皮増殖因子（VEGFR）チロシンキナーゼ阻害剤）、用途別分析（慢性骨髄性白血病（CML）、肺がん、乳がん、腎細胞がん、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AstraZeneca、Johnson & Johnson、Bristol-Myers Squibb、Pfizer、F. Hoffmann-La Roche、Novartis、Boehringer Ingelheim International、Bayer、Eisai ・メーカー別販売量、売上、市場シェア ・チロシンキナーゼ阻害剤の地域別市場分析 ・チロシンキナーゼ阻害剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・チロシンキナーゼ阻害剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・チロシンキナーゼ阻害剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・チロシンキナーゼ阻害剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・チロシンキナーゼ阻害剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・チロシンキナーゼ阻害剤の種類別市場規模2015-2020：BCR-ABLチロシンキナーゼ阻害剤、上皮増殖因子受容体（EGFR）チロシンキナーゼ阻害剤、血管内皮増殖因子（VEGFR）チロシンキナーゼ阻害剤 ・チロシンキナーゼ阻害剤の用途別市場規模2015-2020：慢性骨髄性白血病（CML）、肺がん、乳がん、腎細胞がん、その他 ・チロシンキナーゼ阻害剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Tyrosine Kinase Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tyrosine Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tyrosine Kinase Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tyrosine Kinase Inhibitors market has been segmented into
BCR-ABL Tyrosine Kinase Inhibitor
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
By Application, Tyrosine Kinase Inhibitors has been segmented into:
Chronic Myeloid Leukemia (CML)
Lung Cancer
Breast Cancer
Renal Cell Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tyrosine Kinase Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Tyrosine Kinase Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tyrosine Kinase Inhibitors market.
The report offers in-depth assessment of the growth and other aspects of the Tyrosine Kinase Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tyrosine Kinase Inhibitors Market Share Analysis
Tyrosine Kinase Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tyrosine Kinase Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tyrosine Kinase Inhibitors sales, revenue and market share for each player covered in this report.
The major players covered in Tyrosine Kinase Inhibitors are:
AstraZeneca
Johnson & Johnson
Bristol-Myers Squibb
Pfizer
F. Hoffmann-La Roche
Novartis
Boehringer Ingelheim International
Bayer
Eisai
Among other players domestic and global, Tyrosine Kinase Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tyrosine Kinase Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tyrosine Kinase Inhibitors, with price, sales, revenue and global market share of Tyrosine Kinase Inhibitors in 2018 and 2019.
Chapter 3, the Tyrosine Kinase Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tyrosine Kinase Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tyrosine Kinase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tyrosine Kinase Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tyrosine Kinase Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tyrosine Kinase Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BCR-ABL Tyrosine Kinase Inhibitor
1.2.3 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
1.2.4 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Tyrosine Kinase Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic Myeloid Leukemia (CML)
1.3.3 Lung Cancer
1.3.4 Breast Cancer
1.3.5 Renal Cell Cancer
1.3.6 Others
1.4 Overview of Global Tyrosine Kinase Inhibitors Market
1.4.1 Global Tyrosine Kinase Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche SWOT Analysis
2.5.4 F. Hoffmann-La Roche Product and Services
2.5.5 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim International
2.7.1 Boehringer Ingelheim International Details
2.7.2 Boehringer Ingelheim International Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Boehringer Ingelheim International SWOT Analysis
2.7.4 Boehringer Ingelheim International Product and Services
2.7.5 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eisai SWOT Analysis
2.9.4 Eisai Product and Services
2.9.5 Eisai Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tyrosine Kinase Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tyrosine Kinase Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tyrosine Kinase Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Tyrosine Kinase Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Tyrosine Kinase Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tyrosine Kinase Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Tyrosine Kinase Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Tyrosine Kinase Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Tyrosine Kinase Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tyrosine Kinase Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tyrosine Kinase Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tyrosine Kinase Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Tyrosine Kinase Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Tyrosine Kinase Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tyrosine Kinase Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tyrosine Kinase Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tyrosine Kinase Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tyrosine Kinase Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Tyrosine Kinase Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Tyrosine Kinase Inhibitors Price by Type (2015-2020)
11 Global Tyrosine Kinase Inhibitors Market Segment by Application
11.1 Global Tyrosine Kinase Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Tyrosine Kinase Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Tyrosine Kinase Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tyrosine Kinase Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Tyrosine Kinase Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Tyrosine Kinase Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Tyrosine Kinase Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tyrosine Kinase Inhibitors Market Forecast (2021-2025)
12.2.4 South America Tyrosine Kinase Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tyrosine Kinase Inhibitors Market Forecast (2021-2025)
12.3 Tyrosine Kinase Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Tyrosine Kinase Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Tyrosine Kinase Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Tyrosine Kinase Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Tyrosine Kinase Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Tyrosine Kinase Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tyrosine Kinase Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tyrosine Kinase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tyrosine Kinase Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Tyrosine Kinase Inhibitors Major Business
Table 9. AstraZeneca Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Tyrosine Kinase Inhibitors Product and Services
Table 12. AstraZeneca Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Tyrosine Kinase Inhibitors Major Business
Table 15. Johnson & Johnson Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 16. Johnson & Johnson SWOT Analysis
Table 17. Johnson & Johnson Tyrosine Kinase Inhibitors Product and Services
Table 18. Johnson & Johnson Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Tyrosine Kinase Inhibitors Major Business
Table 21. Bristol-Myers Squibb Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 22. Bristol-Myers Squibb SWOT Analysis
Table 23. Bristol-Myers Squibb Tyrosine Kinase Inhibitors Product and Services
Table 24. Bristol-Myers Squibb Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Tyrosine Kinase Inhibitors Major Business
Table 27. Pfizer Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Tyrosine Kinase Inhibitors Product and Services
Table 30. Pfizer Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Major Business
Table 33. F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 34. F. Hoffmann-La Roche SWOT Analysis
Table 35. F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Product and Services
Table 36. F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Tyrosine Kinase Inhibitors Major Business
Table 39. Novartis Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Tyrosine Kinase Inhibitors Product and Services
Table 42. Novartis Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Boehringer Ingelheim International Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim International Tyrosine Kinase Inhibitors Major Business
Table 45. Boehringer Ingelheim International Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 46. Boehringer Ingelheim International SWOT Analysis
Table 47. Boehringer Ingelheim International Tyrosine Kinase Inhibitors Product and Services
Table 48. Boehringer Ingelheim International Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bayer Basic Information, Manufacturing Base and Competitors
Table 50. Bayer Tyrosine Kinase Inhibitors Major Business
Table 51. Bayer Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 52. Bayer SWOT Analysis
Table 53. Bayer Tyrosine Kinase Inhibitors Product and Services
Table 54. Bayer Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eisai Basic Information, Manufacturing Base and Competitors
Table 56. Eisai Tyrosine Kinase Inhibitors Major Business
Table 57. Eisai Tyrosine Kinase Inhibitors Total Revenue (USD Million) (2018-2019)
Table 58. Eisai SWOT Analysis
Table 59. Eisai Tyrosine Kinase Inhibitors Product and Services
Table 60. Eisai Tyrosine Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Tyrosine Kinase Inhibitors Sales by Manufacturer (2018-2019) (K MT)
Table 62. Global Tyrosine Kinase Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Tyrosine Kinase Inhibitors Sales by Regions (2015-2020) (K MT)
Table 64. Global Tyrosine Kinase Inhibitors Sales Market Share by Regions (2015-2020)
Table 65. Global Tyrosine Kinase Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Tyrosine Kinase Inhibitors Sales by Countries (2015-2020) (K MT)
Table 67. North America Tyrosine Kinase Inhibitors Sales Market Share by Countries (2015-2020)
Table 68. North America Tyrosine Kinase Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020)
Table 70. Europe Tyrosine Kinase Inhibitors Sales by Countries (2015-2020) (K MT)
Table 71. Europe Tyrosine Kinase Inhibitors Sales Market Share by Countries (2015-2020)
Table 72. Europe Tyrosine Kinase Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Tyrosine Kinase Inhibitors Sales by Regions (2015-2020) (K MT)
Table 74. Asia-Pacific Tyrosine Kinase Inhibitors Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Tyrosine Kinase Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Tyrosine Kinase Inhibitors Sales by Countries (2015-2020) (K MT)
Table 77. South America Tyrosine Kinase Inhibitors Sales Market Share by Countries (2015-2020)
Table 78. South America Tyrosine Kinase Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Tyrosine Kinase Inhibitors Sales by Countries (2015-2020) (K MT)
Table 81. Middle East & Africa Tyrosine Kinase Inhibitors Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Tyrosine Kinase Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020)
Table 84. Global Tyrosine Kinase Inhibitors Sales by Type (2015-2020) (K MT)
Table 85. Global Tyrosine Kinase Inhibitors Sales Share by Type (2015-2020)
Table 86. Global Tyrosine Kinase Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 87. Global Tyrosine Kinase Inhibitors Revenue Share by Type (2015-2020)
Table 88. Global Tyrosine Kinase Inhibitors Sales by Application (2015-2020) (K MT)
Table 89. Global Tyrosine Kinase Inhibitors Sales Share by Application (2015-2020)
Table 90. Global Tyrosine Kinase Inhibitors Sales Forecast by Regions (2021-2025) (K MT)
Table 91. Global Tyrosine Kinase Inhibitors Market Share Forecast by Regions (2021-2025)
Table 92. Global Tyrosine Kinase Inhibitors Sales Forecast by Type (2021-2025) (K MT)
Table 93. Global Tyrosine Kinase Inhibitors Market Share Forecast by Type (2021-2025)
Table 94. Global Tyrosine Kinase Inhibitors Sales Forecast by Application (2021-2025)
Table 95. Global Tyrosine Kinase Inhibitors Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tyrosine Kinase Inhibitors Picture
Figure 2. Global Sales Market Share of Tyrosine Kinase Inhibitors by Type in 2019
Figure 3. BCR-ABL Tyrosine Kinase Inhibitor Picture
Figure 4. Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Picture
Figure 5. Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Picture
Figure 6. Tyrosine Kinase Inhibitors Sales Market Share by Application in 2018
Figure 7. Chronic Myeloid Leukemia (CML) Picture
Figure 8. Lung Cancer Picture
Figure 9. Breast Cancer Picture
Figure 10. Renal Cell Cancer Picture
Figure 11. Others Picture
Figure 12. Global Tyrosine Kinase Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Tyrosine Kinase Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Tyrosine Kinase Inhibitors Sales Market Share by Manufacturer in 2019
Figure 33. Global Tyrosine Kinase Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Tyrosine Kinase Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Tyrosine Kinase Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Tyrosine Kinase Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 40. Global Tyrosine Kinase Inhibitors Revenue Market Share by Regions in 2018
Figure 41. North America Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Europe Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
Figure 44. South America Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020)
Figure 46. North America Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Tyrosine Kinase Inhibitors Sales Market Share by Countries (2015-2020)
Figure 48. North America Tyrosine Kinase Inhibitors Sales Market Share by Countries in 2018
Figure 49. North America Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Tyrosine Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure 51. United States Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Tyrosine Kinase Inhibitors Revenue Market Share by Countries in 2019
Figure 57. Germany Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Tyrosine Kinase Inhibitors Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Tyrosine Kinase Inhibitors Revenue Market Share by Regions 2019
Figure 65. China Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Tyrosine Kinase Inhibitors Sales Market Share by Countries in 2019
Figure 72. South America Tyrosine Kinase Inhibitors Revenue Market Share by Countries in 2019
Figure 73. Brazil Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Tyrosine Kinase Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Tyrosine Kinase Inhibitors Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Tyrosine Kinase Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Tyrosine Kinase Inhibitors Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Tyrosine Kinase Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Tyrosine Kinase Inhibitors Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Tyrosine Kinase Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Tyrosine Kinase Inhibitors Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Tyrosine Kinase Inhibitors Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Tyrosine Kinase Inhibitors Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Tyrosine Kinase Inhibitors Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Tyrosine Kinase Inhibitors Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
チロシンキナーゼJAK阻害剤の世界市場 2020年 Market Overview The Tyrosine Kinase JAK Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- チロシンプロテインキナーゼ受容体TYRO3の世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Receptor TYRO3 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosi…
- チロシンプロテインキナーゼCSKの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase CSK market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …
- チロシンプロテインキナーゼLynの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Lyn market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …
- チロシンプロテインキナーゼFynの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Fyn market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …